Impact of rapid treatment for pediatric status epilepticus (VIDEO)

Article

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a multicenter observational study published in JAMA Neurology that looked at time to treatment in children with refractory convulsive status epilepticus and the impact on mortality.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses a multicenter observational study published in JAMA Neurology that looked at time to treatment in children with refractory convulsive status epilepticus and the impact on mortality.

Recent Videos
Michael, Kruer, MD
Benefits of genetic sequencing for cerebral palsy patients
Michael Kruer, MD
Michael Kruer, MD explains genetic testing and cerebral palsy
H. Westley Phillips, MD
Awareness for epilepsy surgery among drug-resistant pediatric patients
H. Westley Phillips, MD
Identifying drug-resistant epilepsy patients in primary care
Alan Percy, MD
The pediatrician's role in prescribing trofinetide for Rett syndrome
Alan Percy, MD
Discussing trofinetide data, FDA approval for Rett syndrome with Alan Percy, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
DB-OTO improved hearing to normal in child with profound genetic deafness
William Gallentine, DO
Discussing epilepsy's initial signs and treatments in the pediatric population
Rob Knight, PhD | Image Credit: Contemporary Pediatrics®
Developing biomarkers for gut and neurological, cognitive functioning associations in children
How are gut microbiomes and pediatric neurological, cognitive conditions being linked?
How are gut microbiomes and pediatric neurological, cognitive conditions being linked?
Related Content
FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA expands use of eculizumab to patients 6 years and up with generalized myasthenia gravis

Joshua Fitch, Senior Editor
March 4th 2025
Article

First approved for PNH in 2007, the monoclonal antibody is now the first and only treatment for pediatric patients living with gMG.

Site Logo

PODCAST: Auditory brain stem implants in young children.

January 14th 2016
Podcast

Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.

Weekly review: Several key FDA approvals, new puzzler case, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: Several key FDA approvals, new puzzler case, and more

Joshua Fitch, Senior Editor
February 17th 2025
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

FDA approves non-invasive risdiplam tablet for spinal muscular atrophy | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves non-invasive risdiplam tablet for spinal muscular atrophy

Joshua Fitch, Senior Editor
February 12th 2025
Article

The new risdiplam tablet is suitable for those aged 2 years and older who weigh more than 44 lbs, according to Genentech.

Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1 | Image Credit: © ธนากร บัวพรหม - © ธนากร บัวพรหม - stock.adobe.com.

Positive data reported for Trappsol Cyclo in patients 3 years and under with NPC1

Joshua Fitch, Senior Editor
February 7th 2025
Article

Cyclo Therapeutics has enrolled 10 patients in a single-arm sub-study treating newborns to 3 years of age, evaluating the Trappsol Cyclo in the youngest subsets.

FDA news in pediatrics: January 2025 Image Credit: Adobe Stock

FDA news in pediatrics: January 2025

Patrick Campbell
February 5th 2025
Article

A recap of the FDA submissions and regulatory decisions in pediatrics from January 2025.

© 2025 MJH Life Sciences

All rights reserved.